12463 Rancho Bernardo Road., Suite 198
28 articles with Mentice Inc.
Thomas Jefferson University Hospitals and Mentice to establish a Simulation Center of Excellence for Interventional Radiology
Thomas Jefferson University Hospitals and Mentice have formed a strategic collaboration to establish a Simulation Center of Excellence uniting Jefferson's world-class interventional radiology team with Mentice's virtual patient technology aiming to elevate clinical training and to introduce advanced Virtual Reality simulation solutions for physicians in clinical practice.
An annual general meeting was held in Mentice AB on 6 May 2021.
Continued strong order intake, with the strongest order intake figure for a first quarter in Mentice's history on the back end of our strongest order intake for a fourth quarter ever.
Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on April 28 at 9:30 CET
Mentice AB announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Elisabet Lund.
Mentice AB, a leading supplier of high-tech solutions for simulation in the medical sector, with a focus on endovascular procedures, announced the appointment of Pontus Appelqvist as Vice President and General Manager for Asia Pacific.
The shareholders of Mentice AB, reg. no. 566556-4241, are hereby given notice to attend the annual shareholders' meeting to be held on 6 May 2021 by completing a form for postal voting.
Strong order intake and substantial improvement of the company's order book as well as operating cash flow Fourth quarter
Mentice's CEO Göran Malmberg to present the company's year-end 2020 report at a webcast conference call on February 4 at 9:30 CET
Mentice AB announces that the company will present its year-end report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Elisabet Lund.
Mentice AB, a leading supplier of high-tech solutions for simulation in the medical sector, with focus on endovascular procedures, has announced changes to its organization.
Issuance of new shares in Mentice AB (publ) has been registered with the Swedish Companies Registration Office
Regarding the acquisition of the assets from Vascular Simulations Inc 571,974 shares have been issued at a subscription price of SEK 86.16 and regarding the acquisition of the assets from EQIP Inc, 9,469 shares have been issued at a subscription price of SEK 84.28.
- Combined portfolio will enhance Mentice's endovascular simulation offerings with world class replication solutions - Acquisition to expand Mentice's global customer base and offer a strong entry into previously untapped market segments
Mentice AB announced the appointment of Thanos Karras as the company's new General Manager for Americas.
Mentice Expands its Coronary Product Portfolio With an Advanced Software Solution for Coronary Interventions
Coronary Advanced to Help Fellows and Attending Interventional Cardiologists to Perfect Skills in Complex Scenarios
VIST® G7 Brings Reality to Complex Interventions and Introduces a Scalable and Flexible Platform for Advanced Future Applications
Mentice AB, a world leader in simulation solutions for endovascular therapies, introduces Coronary Intermediate as the latest software addition to the Coronary Product Portfolio.
Mentice AB, a world leader in simulation solutions for endovascular therapies, will be showcasing the first of-its-kind flexible Coronary Essentials training solution at the 20th International Meeting on Simulation in Healthcare in San Diego from January 19 to January 22.
Mentice Introduces its Advanced, High-fidelity VIST® One TEE Echocardiography Training Solution at TCT Symposium 2019
Featuring real-time 2D and 3D echo and multiplanar reconstruction, VIST® One TEE is the most sophisticated TEE Training solution available in the market today.
Mentice Introduces Today Subscription-based Pricing for its Endovascular-Simulation Training Software
Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies, announces today the introduction of software subscription for its VIST® endovascular simulation platform to hospitals and health systems.
Mentice today announced the appointment of Dr. David J. Ballard as Chief Clinical Officer and Executive Vice President of the Mentice Group.
Mentice announced today the appointment of a new independent member to its Board of Directors.